ZAI LAB LIMITED

ZLAB ·Healthcare, Drug Manufacturers - General
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Assets
Cash & Equivalents $679.6M $449.7M $790.2M $1.01B $964.1M $442.1M $75.9M $63.0M
Accounts Receivable $106.1M $85.2M $59.2M $40.0M $47.5M $5.2M $3.8M
Inventory $74.7M $39.9M $44.8M $31.6M $19.0M $13.1M $6.0M
Total Current Assets $1.02B $1.05B $939.6M $1.12B $1.50B $1.22B $292.5M
Property, Plant & Equipment $47.4M $48.0M $53.7M $57.9M $43.1M $29.2M $21.4M
Goodwill
Intangible Assets (Excl. Goodwill) $76.1M $56.0M $13.4M $1.5M $1.8M $1.5M $1.1M
Total Assets $1.17B $1.19B $1.04B $1.22B $1.61B $1.30B $355.2M
Liabilities
Accounts Payable $141.6M $100.9M $113.0M $66.0M $126.2M $62.6M $22.7M
Total Current Liabilities $416.2M $299.4M $203.1M $139.8M $192.9M $98.0M $46.6M
Long-Term Debt
Total Liabilities $456.9M $344.9M $240.2M $174.5M $230.0M $128.3M $60.5M
Stockholders' Equity
Retained Earnings $-2.63B $-2.45B $-2.20B $-1.86B $-1.42B $-713.6M $-444.7M
Total Stockholders' Equity $715.5M $840.9M $796.1M $1.05B $1.38B $1.17B $294.7M $251.1M
← Newer Page 1 of 2 Older →